Election Day is just about here, marking an end to the unpredictable ride that has been the 2024 presidential race following ...

On Monday, Royalty Pharma plc (RPRX) stock saw a modest uptick, ending the day at $27.2 which represents a slight increase of $0.10 or 0.37% from the prior close of $27.1. The stock opened at $27.52 ...

Verona Pharma (Nasdaq: VRNA) is already recording millions of dollars in revenue after launching its lead drug in August ...

To help foot the bill to launch its approved graft-versus-host disease drug Niktimvo and the expected launch of its leukemia treatment revumenib, Syndax has struck a $350 million licensing deal with ...

Gland Pharma Q2 Results Live : Gland Pharma declared their Q2 results on 04 Nov, 2024, reporting a topline increase of 2.36% ...

The generic injectable-focused company's consolidated net profit declined to Rs 163.5 crore in Q2 FY25 from Rs 194 crore in ...

India's Mankind Pharma reported a better-than-expected second-quarter profit on Tuesday, driven by strong demand for its drugs to treat long-term illnesses, such as diabetes and cardiovascular ...

Q3 2024 Earnings Call Transcript November 4, 2024 Verona Pharma plc beats earnings expectations. Reported EPS is $-0.08819, ...

He has gotten large donations from and owns hundreds of thousands of dollars in stocks in drug and medical device companies.

The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as ...

NEW YORK (Reuters) - Purdue Pharma is close to a new bankruptcy settlement with its owners, members of the wealthy Sackler ...

Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro ...